In the name of full disclosure, I am not a medical expert, nor a financial investment expert.
However I am considered a bit of an expert in some of the related technological areas.
another diabetes technology to look at would be TNDM, which is going to be the wave of the future as far as insulin pumps are concerned.
I suspect this is all bogus since it was posted in relationship to ISO Standard 594-1 however this makes no sense at all, there are never any Luer locks on lancets, only on infusion kits and syringes.
A quick search for ISO 594-1 will show what the standard is all about.
Not that I know of, though this is from a couple days back.
Chabibi, Can you provide a link to the FDA site where you found this information? Or post the details in ivrit so I can understand it better than your english. :-)
I cannot find any document on the public FDA website indicating a problem.
In general there is a difference between a needle and a lancet. If you use a glucose meter you need to use a lancing device with a lancet. but no needles. the ISO standard is for needles I found no mention of a lancet within the standard. I cannot search the internal FDA SP site for details since I would get fired.
Can you post the reference number or link to the FDA document so I may read exactly whet the FDA problem was?
I just can't understand how this was missed.
The iBGStar® blood glucose meter is also integrated with the iphone yet my impression is that it is a total dud as far as sales. what makes the Dario different?
Yes, we'll see a bump, but they will need to prove that they can get users that will make us money.
The steps to profits for us stockholders have been laid out in an earlier post.